A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies
Niina Veitonmäki(Pure Biologics (Poland)), Pieter Spee(Pure Biologics (Poland))
Cited by 0
Related Papers
First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies
|International Journal of Cancer|2019|142
p130‐Angiomotin associates to actin and controls endothelial cell shape
|FEBS Journal|2006|121